Protocol to analyze 1D and 2D mass spectrometry data from glioblastoma tissues for cancer diagnosis and immune cell identification
In context of cancer diagnosis-based mass spectrometry (MS), the classification model created is crucial. Moreover, exploration of immune cell infiltration in tissues can offer insights within the tumor microenvironment. Here, we present a protocol to analyze 1D and 2D MS data from glioblastoma tissues for cancer diagnosis and immune cells identification. We describe steps for training the most optimal model and cross-validating it, for discovering robust biomarkers and obtaining their corresponding boxplots as well as creating an immunoscore based on MS-imaging data. For complete details on the use and execution of this protocol, please refer to Zirem et al.<sup>1</sup>.
Authors
- Isabelle Fournier (ORCID: https://orcid.org/0000-0003-1096-5044)
- Michel Salzet (ORCID: https://orcid.org/0000-0003-4318-0817)
- Léa Ledoux (ORCID: https://orcid.org/0009-0007-8963-7073)
- Yanis Zirem (ORCID: https://orcid.org/0009-0003-1237-4448)
Institutions
- Inserm (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (FR)
Publication Details
- Journal
- STAR Protocols
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.xpro.2024.103285
- Citations
- 3
- Primary Topic
- Mass Spectrometry Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.72
Funders
- Université de Lille
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Institut Universitaire de France
- Région Hauts-de-France